Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy. [electronic resource]
Producer: 20210108Description: 910-916 p. digitalISSN:- 1468-2079
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Central Serous Chorioretinopathy -- complications
- Choroidal Neovascularization -- diagnostic imaging
- Chronic Disease
- Coloring Agents -- administration & dosage
- Female
- Fluorescein Angiography
- Humans
- Indocyanine Green -- administration & dosage
- Intravitreal Injections
- Male
- Middle Aged
- Multimodal Imaging
- Ranibizumab -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Retrospective Studies
- Subretinal Fluid
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.